Table: Phoenixbio - 9-MTH group results

PhoenixBio

12/02/2021 06:30

Feb 12 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2020        Dec 31, 2019      Mar 31, 2021  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            501 mln             833 mln           992 mln    
                 (-39.8 pct)         (+0.3 pct)        (-24.3 pct)  
  Operating     loss 363 mln        loss 200 mln      loss 300 mln  
  Recurring     loss 336 mln        loss 182 mln      loss 273 mln  
  Net           loss 347 mln        loss 184 mln      loss 284 mln  
  EPS          loss 108.00 yen     loss 63.11 yen    loss 87.97 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T